The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 417.50
Bid: 410.00
Ask: 425.00
Change: 0.00 (0.00%)
Spread: 15.00 (3.659%)
Open: 417.50
High: 425.00
Low: 417.50
Prev. Close: 417.50
AVG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Award of Options, Issue of Equity & Total Voting Rights

19 Dec 2012 09:15

AVINGTRANS PLC - Award of Options, Issue of Equity & Total Voting Rights

AVINGTRANS PLC - Award of Options, Issue of Equity & Total Voting Rights

PR Newswire

London, December 19

AVINGTRANS PLC Award of Options, Issue of Equity and Total Voting Rights

Avingtrans plc ("Avingtrans" or "the Company") announces that the Company hastoday, under the terms of the Company's CSOP share scheme (the "CSOP") and itsExecutive Shared Ownership Plan ("the ExSOP "), made a grant of awards overordinary shares of 5p each in the Company ("Ordinary Shares") to directors andsenior managers, as set out below.

Awards under the CSOP

On 19 December 2012, the Board of Avingtrans, in accordance with the Company'sCSOP, granted options over 189,000 Ordinary Shares at an option price of 96.0pence per share. The following were issued to Directors:

Name Number of options over Total number of options Ordinary Shares granted over Ordinary Shares now held S McQuillan 30,000 30,000 SM King 30,000 105,000 PJ Kenny 20,000 75,000

All of the options granted may not be exercised until 3 years from the date ofgrant and are subject to a performance condition. The performance condition foreach of these options is that the increase in adjusted EPS must be at leastequal to the increase in RPI over the vesting period.

Awards under the ExSOP

On 18 December 2012, the Board of Avingtrans, in accordance with the Company'sExSOP, granted options over 330,000 Ordinary Shares at an option price of 96.0pence per share. The following were issued to Directors:

Director Number of Ordinary Beneficial interest in Shares subject to awards Ordinary Shares Stephen McQuillan 145,000 150,000 Stephen King 95,000 135,000 Peter Kenny 25,000 40,000

Furthermore, one senior manager has been granted awards over a total of 85,000Ordinary Shares.

Consequently, in order to satisfy the awards under the ExSOP, application hasbeen made for admission to trading on AIM of a total of 330,000 Ordinary Shares("Admission"). It is expected that Admission will be effective on 21 December2012.

Under the provisions of the ExSOP, Ordinary Shares are jointly owned betweenthe individuals above and by an employees' share trust, on terms, similar to ashare option scheme, whereby the participant can benefit only from the futuregrowth in the value of the Ordinary Shares above the closing market value ofthe shares on the award date (being therefore the closing market value on 18December 2012) in excess of a carrying cost.

Awards are subject to a performance and participants may not normally realiseany such benefit before 21 December 2015. The performance condition for each ofthe ExSOP options is that the increase in adjusted EPS must be at least equalto the increase in RPI over the vesting period

Subsequent to issue of the Ordinary Shares as above, the Company's total issuedshare capital is 26,959,397 Ordinary Shares. Avingtrans does not hold anyOrdinary Shares in treasury. Therefore, the total number of voting rights inAvingtrans is 26,959,397.

The above figure 26,959,397 may be used by shareholders as the denominator forthe calculations by which they will determine if they are required to notifytheir interest in, or a change to their interest in, Avingtrans under the FSA'sDisclosure and Transparency Rules.

Enquiries:Avingtrans plc 0115 949 9020Steve McQuillan, CEO

Numis Securities Limited 020 7260 1000

David Poutney (Corporate Broking)

Richard Thomas (Corporate Finance and Nominated Adviser)

Newgate Threadneedle 020 7653 9850(Financial PR)Josh RoystonHeather Armstrong
Date   Source Headline
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins
28th Sep 20235:54 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSPreliminary results for the year ended 31 May 2023
25th Sep 20237:00 amRNSHolding(s) in Company
18th Sep 20237:00 amRNSCompletion of Acquisition of Adaptix Ltd
4th Sep 20237:00 amRNSBoard Update
7th Aug 20237:00 amRNSAcquisition of Slack & Parr and Adaptix update
13th Jul 20237:00 amRNSTrading Update & Possible Acquisition of Adaptix
5th Jun 20237:00 amRNSBoard Changes
22nd Feb 20237:00 amRNSInterim Results
15th Feb 20237:00 amRNSAdaptix appoints Willem Baralt as new Chairman
30th Jan 20237:00 amRNSAdaptix secures 510(k) clearance from FDA
27th Jan 20231:19 pmRNSEmployee & PDMR Share Incentive Awards
23rd Jan 20236:12 pmRNSPDMR Dealings
18th Jan 20237:00 amRNSAdditional Investment in Magnetica
16th Jan 20237:00 amRNSTrading Update, Acquisitions and Notice of Results
23rd Dec 20228:30 amRNSExercise of Options, PDMR Dealings & TVR
14th Dec 20227:00 amRNSSteve McQuillan appointed as Chairman of Adaptix
17th Nov 20223:56 pmRNSResult of Annual General Meeting
28th Sep 20227:00 amRNSPreliminary results for the year ended 31 May 2022
27th Jul 20222:38 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSTrading Update and Notice of Results
11th Apr 20227:00 amRNSHayward Tyler Secures Nuclear Contracts worth $7m
6th Apr 202212:59 pmRNSExercise of Options and Total Voting Rights
29th Mar 20225:13 pmRNSPDMR Dealing
21st Mar 20227:00 amRNSEnergy Steel Secures Nuclear Contract worth $4.1m
17th Mar 20227:00 amRNSContract Wins
23rd Feb 20227:00 amRNSDirectorate Change
23rd Feb 20227:00 amRNSInterim Results
20th Jan 20227:00 amRNSTrading Update, Notice of Results and Investment
29th Nov 20215:57 pmRNSEmployee & PDMR Share Incentive Awards
22nd Nov 20212:32 pmRNSExercise of Options, PDMR Dealings and TVR
18th Nov 202112:41 pmRNSResult of AGM
13th Oct 20217:00 amRNSInvestment in emerging medtech leader, Adaptix
29th Sep 20217:00 amRNSPreliminary Results for the year ended 31 May 2021
12th Aug 202112:20 pmRNSExercise of Options and Total Voting Rights
12th Jul 202110:51 amRNSExercise of Options, PDMR Dealings and TVR
12th Jul 20217:00 amRNSAvingtrans’ businesses nuclear contract
8th Jul 20217:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.